Pharmaceutical compositions for the treatment of diseases related to neurotrophines
CA 2489965 C · Owner: Mimetech S.R.L. · Inventors: Torcia, Maria; Guarna, Antonio; Cozzolino, Federico
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention refers to pharmaceutical preparations including as active compounds 3-aza-bicyclo3.2.1octane derivatives of general formula (I) and/or their dimers of general formula (II) and (III) acting as agonists of human neurotrophines. Therefore, such compounds of formula (I) (II) and (III) , are useful for treatment of diseases in which the neurotrophine functions are involved in defect, particularly of Nerve Growth Factor (NGF) such as , neurodegenerative diseases of central nervous system (CNS) acquired , immundeficiency due to a reduced NGF biodisponibility or morbous conditions , in which the stimulus of neoangiogenesis process is convenient.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 18, 2003 and granted July 31, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 18, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 18, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.